This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Rhode Island Hospital. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Masafumi Shimoda: Innovator in Dendritic Cell Vaccines
Introduction
Masafumi Shimoda is a notable inventor based in Providence, RI (US). He has made significant contributions to the field of immunotherapy, particularly in the development of dendritic cell vaccines.
Latest Patents
Masafumi Shimoda holds a patent for "Dendritic cell vaccines for asparaginyl-β-hydroxylase expressing tumors." This innovative vaccine contains AAH-loaded mature dendritic cells aimed at treating AAH-expressing tumors in mammalian subjects. The method of producing primed dendritic cells involves contacting isolated dendritic cells with an antigen such as AAH, followed by exposure to a combination of cytokines like GM-CSF and IFN-γ.
Career Highlights
Shimoda is affiliated with Rhode Island Hospital, where he continues to advance his research and development efforts in the field of cancer treatment. His work focuses on harnessing the immune system to combat tumors effectively.
Collaborations
One of his notable collaborators is Jack Raymond Wands, with whom he has worked on various projects related to immunotherapy and cancer research.
Conclusion
Masafumi Shimoda's contributions to dendritic cell vaccines represent a significant advancement in cancer treatment. His innovative approach and dedication to research continue to inspire progress in the field of immunotherapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile